The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sombroek, C. C.
Right arrow Articles by de Gruijl, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sombroek, C. C.
Right arrow Articles by de Gruijl, T. D.
The Journal of Immunology, 2002, 168: 4333-4343.
Copyright © 2002 by The American Association of Immunologists

Prostanoids Play a Major Role in the Primary Tumor-Induced Inhibition of Dendritic Cell Differentiation

Claudia C. Sombroek*, Anita G. M. Stam*, Allan J. Masterson{dagger}, Sinéad M. Lougheed{dagger}, Marcel J. A. G. Schakel*, Chris J. L. M. Meijer*, Herbert M. Pinedo{dagger}, Alfons J. M. van den Eertwegh{dagger}, Rik J. Scheper1,* and Tanja D. de Gruijl{dagger}

Departments of * Pathology and {dagger} Medical Oncology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands

Production of immunosuppressive factors is one of the mechanisms by which tumors evade immunosurveillance. Soluble factors hampering dendritic cell (DC) development have recently been identified in culture supernatants derived from tumor cell lines. In this study, we investigated the presence of such factors in 24-h culture supernatants from freshly excised solid human tumors (colon, breast, renal cell carcinoma, and melanoma). While primary tumor-derived supernatant (TDSN) profoundly hampered the in vitro DC differentiation from CD14+ plastic-adherent monocytes or CD34+ precursors (based on morphology and CD1a/CD14 phenotype), the effects of tested tumor cell line-derived supernatants were minor. Cyclooxygenase (COX)-1- and COX-2-regulated prostanoids present in the primary TDSN were found to be solely responsible for the observed hampered differentiation of monocyte-derived DC (MoDC). In contrast, both prostanoids and IL-6 were found to contribute to the TDSN-induced inhibition of DC differentiation from CD34+ precursor cells. While the addition of TDSN during differentiation interfered with the ability of CD34-derived DC to stimulate a primary allogeneic T cell response, it actually increased this ability of MoDC. These opposite effects were correlated to different effects of the TDSN on the expression levels of CD86 and HLA-DR on the DC from the different precursor origins. Although TDSN increased the T cell-stimulatory capacity of MoDC, TDSN inhibited the IL-12 production and increased the IL-10 production of MoDC, thus skewing them to a type-2 T cell-inducing phenotype. In conclusion, this study demonstrates that primary tumors negatively impact DC development and function through COX-1 and -2 regulated factors, whereas tumor-derived cell lines may lose this ability upon in vitro propagation.




This article has been cited by other articles:


Home page
J. Immunol.Home page
E. Eruslanov, S. Kaliberov, I. Daurkin, L. Kaliberova, D. Buchsbaum, J. Vieweg, and S. Kusmartsev
Altered Expression of 15-Hydroxyprostaglandin Dehydrogenase in Tumor-Infiltrated CD11b Myeloid Cells: A Mechanism for Immune Evasion in Cancer
J. Immunol., June 15, 2009; 182(12): 7548 - 7557.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D.-M. Kuang, Q. Zhao, J. Xu, J.-P. Yun, C. Wu, and L. Zheng
Tumor-Educated Tolerogenic Dendritic Cells Induce CD3{epsilon} Down-Regulation and Apoptosis of T Cells through Oxygen-Dependent Pathways
J. Immunol., September 1, 2008; 181(5): 3089 - 3098.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. J. J. van der Vliet, R. Wang, S. C. Yue, H. B. Koon, S. P. Balk, and M. A. Exley
Circulating Myeloid Dendritic Cells of Advanced Cancer Patients Result in Reduced Activation and a Biased Cytokine Profile in Invariant NKT Cells
J. Immunol., June 1, 2008; 180(11): 7287 - 7293.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Tonello and G. Poli
Tubal ectopic pregnancy: macrophages under the microscope
Hum. Reprod., October 1, 2007; 22(10): 2577 - 2584.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. D. de Gruijl, C. C. Sombroek, S. M. Lougheed, D. Oosterhoff, J. Buter, A. J. M. van den Eertwegh, R. J. Scheper, and H. M. Pinedo
A Postmigrational Switch among Skin-Derived Dendritic Cells to a Macrophage-Like Phenotype Is Predetermined by the Intracutaneous Cytokine Balance.
J. Immunol., June 15, 2006; 176(12): 7232 - 7242.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. van de Ven, M. C. de Jong, A. W. Reurs, A. J. N. Schoonderwoerd, G. Jansen, J. H. Hooijberg, G. L. Scheffer, T. D. de Gruijl, and R. J. Scheper
Dendritic Cells Require Multidrug Resistance Protein 1 (ABCC1) Transporter Activity for Differentiation
J. Immunol., May 1, 2006; 176(9): 5191 - 5198.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Gottfried, L. A. Kunz-Schughart, S. Ebner, W. Mueller-Klieser, S. Hoves, R. Andreesen, A. Mackensen, and M. Kreutz
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression
Blood, March 1, 2006; 107(5): 2013 - 2021.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. P.J.M. van Gisbergen, C. A. Aarnoudse, G. A. Meijer, T. B.H. Geijtenbeek, and Y. van Kooyk
Dendritic Cells Recognize Tumor-Specific Glycosylation of Carcinoembryonic Antigen on Colorectal Cancer Cells through Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Nonintegrin
Cancer Res., July 1, 2005; 65(13): 5935 - 5944.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. de Jong, M. I. E. van Poelgeest, J. M. van der Hulst, J. W. Drijfhout, G. J. Fleuren, C. J. M. Melief, G. Kenter, R. Offringa, and S. H. van der Burg
Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6
Cancer Res., August 1, 2004; 64(15): 5449 - 5455.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. R. Brown and R. N. DuBois
Cyclooxygenase-2 in Lung Carcinogenesis and Chemoprevention: Roger S. Mitchell Lecture
Chest, May 1, 2004; 125(5_suppl): 134S - 140S.
[Full Text] [PDF]


Home page
J. Immunol.Home page
D. Giordano, D. M. Magaletti, E. A. Clark, and J. A. Beavo
Cyclic Nucleotides Promote Monocyte Differentiation Toward a DC-SIGN+ (CD209) Intermediate Cell and Impair Differentiation into Dendritic Cells
J. Immunol., December 15, 2003; 171(12): 6421 - 6430.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Rivoltini, C. Castelli, M. Carrabba, V. Mazzaferro, L. Pilla, V. Huber, J. Coppa, G. Gallino, C. Scheibenbogen, P. Squarcina, et al.
Human Tumor-Derived Heat Shock Protein 96 Mediates In Vitro Activation and In Vivo Expansion of Melanoma- and Colon Carcinoma-Specific T Cells
J. Immunol., October 1, 2003; 171(7): 3467 - 3474.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Hayashi, T. Hideshima, M. Akiyama, N. Raje, P. Richardson, D. Chauhan, and K. C. Anderson
Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytes
Blood, August 15, 2003; 102(4): 1435 - 1442.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.